Clinical Trials Logo

Clinical Trial Summary

It is now accepted that physical activity is not deleterious in myopathies, including muscular dystrophies. In patients suffering from facioscapulohumeral dystrophy (FSHD), aerobic training has been reported to be associated with physiological and functional positive effects without alteration in quality of life. Van der Kooi et al. (2005) and Cup et al. (2007) studies suggest that the combination of endurance and strength trainings is even more relevant. However, only a few controlled and randomized studies have been conducted on this topic and the impact of such training programs on skeletal muscle regenerative capacities has not been addressed yet. Moreover, due to the fact that training programs are mainly performed on short-term supervised periods, there is a lack of knowledge regarding long-term effects, patient's autonomy and whether or not practice of regular exercise can be maintained in patient's daily life. Also, only a few experiments report an integrative view of potential benefits of such programs on functional, biological and quality of life.


Clinical Trial Description

The present project is the second phase of a study for which the first phase currently financed by AFM is in progress and aims to establish a program of adapted physical training performed at the patient's home under supervision. This program was developed in order to try to meet the two following requirements: 1) to be compatible with the daily professional/social activity of patients so it can be integrated in their life routine; 2) to be intense enough so functional benefits can be induced. The first phase is a controlled and randomized study where patients with FSHD participate in a 6-months supervised training program combining aerobic and strength training sessions on an ergocycle.

This second phase of our research project aims to evaluate whether a long-term integration of this adapted training program into patients' lifestyle is possible. The same tools, same method and same measurements of training program will be used with remote monitoring, less frequent as it was in the first phase, over a period of 24 months. This second experimental work will also be based on multi-factorial evaluations, i.e. biological, physiological, functional, and quality of life questionnaires and remains collaboration between Universities of Saint Etienne (L. Féasson), Grenoble (B Wuyam) and Örebro (F Kadi) within the Rhône-Alpes Reference Centre for Rare Neuromuscular Diseases (JC Antoine). ;


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT01689480
Study type Observational
Source Centre Hospitalier Universitaire de Saint Etienne
Contact
Status Completed
Phase N/A
Start date December 2011
Completion date September 2015

See also
  Status Clinical Trial Phase
Completed NCT01970735 - Clinical, Genetic and Epigenetic Characterization of Patients With FSHD Type 1 and FSHD Type 2 N/A
Completed NCT01116570 - Physical Training Introduction in Lifestyle of Facioscapulohumeral Dystrophy Patients N/A
Completed NCT02032979 - Neurological and Psychiatric Comorbidities Patients With FSHD 1 and 2 N/A
Completed NCT04154098 - Evaluation of a Textile Scapula Orthosis N/A
Completed NCT00004685 - Randomized Study of Albuterol in Patients With Facioscapulohumeral Muscular Dystrophy N/A
Recruiting NCT06227182 - Magnetic Resonance Imaging and Ultrasound Comparison With Load Evaluation
Recruiting NCT05747924 - Phase 1/2 Study of AOC 1020 in Adults With Facioscapulohumeral Muscular Dystrophy (FSHD) Phase 1/Phase 2
Completed NCT04999735 - Digital Biotyping of FSHD Patients and Controls